Register to chat with like-minded investors on our interactive forums.
The current OGEN market cap is 3.41M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13k | 8k | 0 | 0 | 0 |
| Operating Income | -3.11M | -2.1M | -12.8M | -2.46M | -2.31M |
| Net Income | -3.05M | -2.01M | -12.75M | -2.45M | -2.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 87k | 132k | 38k |
| Operating Income | -15.88M | -26.64M | -15.77M | -14.42M | -20.91M |
| Net Income | -15.57M | -26.43M | -15.71M | -14.29M | -20.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.46M | 7.9M | 4.97M | 3.53M | 2.71M |
| Total Liabilities | 1.21M | 1.4M | 1.8M | 909k | 1.38M |
| Total Equity | 7.26M | 6.5M | 3.17M | 2.63M | 1.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.75M | 18.68M | 28.23M | 14.76M | 4.97M |
| Total Liabilities | 2.52M | 1.84M | 1.75M | 1.75M | 1.8M |
| Total Equity | 17.23M | 16.85M | 26.49M | 13.01M | 3.17M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.69M | -6.19M | -7.29M | -3.06M | -4.61M |
| Investing | N/A | 64k | -936k | N/A | N/A |
| Financing | -268k | 464k | 284k | 1.65M | 2.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.01M | -16.95M | -13.47M | -15.23M | -7.29M |
| Investing | -25k | N/A | -44k | -116k | -936k |
| Financing | 11.1M | 16.33M | 23.14M | -495k | 284k |
| Market Cap | 3.41M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 12.21M |
| Average Volume (1 week) | 1.16M |
| Average Volume (1 Month) | 637.97k |
| 52 Week Change | -92.13% |
| 52 Week High | 7.74 |
| 52 Week Low | 0.2542 |
| Spread (Intraday) | 0.01 (5.12%) |
| Company Name | Oragenics Inc |
| Address |
101 east kennedy boulevard tampa, florida 33602 |
| Website | https://www.oragenics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
